C–S@PANI composite with a polymer spherical network structure for high performance lithium–sulfur batteries

Literature Information

Publication Date 2015-11-05
DOI 10.1039/C5CP05447H
Impact Factor 3.676
Authors

Junkai Wang, Kaiqiang Yue, Xiaodan Zhu, Kang L. Wang


View Original

Abstract

A unique C–S@PANI composite with a conductive polymer spherical network (PSN) has been successfully designed and synthesized by a simple processing approach. The PSN framework is formed at the surface of the oxidized carbon black by conductive polymer self-assembly and grafting, followed by pouring elemental sulfur into the pores of the polymer matrix. As the cathode material for lithium–sulfur batteries, the C–S@PANI composite delivered a high specific capacity of 1453 mA h g−1 at a 0.1 C current rate and a stable cycling performance of 948 mA h g−1 after 200 cycles. The composite also demonstrated high capacities of 922 and 581 mA h g−1 at 50 °C and 0 °C, respectively, after 200 cycles. The conductive PANI coatings were connected with the C–S core–shell composites to form a three-dimensional conducting network, which improves the utilization of the active mass and dual conduction of Li+ and electrons, while at the same time encapsulating sulfur into the PANI hollow spherical network. The structure effectively inhibits the dissolution and migration of polysulfides into the electrolyte, while improving the cycling stability and the coulombic efficiency of the electrode at high current rates, especially the low temperature electrochemical properties of Li–S batteries.

Related Literature

Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155)

Tasaduq Hussain Wani, Goutam Chowdhury, Anindita Chakrabarty

2021-02-15 Research Article

DOI: 10.1039/D0MD00383B

Fragment-based drug discovery: opportunities for organic synthesis

Jeffrey D. St. Denis, Richard J. Hall, Christopher W. Murray, Tom D. Heightman, David C. Rees

2020-12-24 Review Article

DOI: 10.1039/D0MD00375A

Target 2035 – update on the quest for a probe for every protein

Susanne Müller, Suzanne Ackloo, Arij Al Chawaf, Hartmut Beck, Shaunna Beedie, Ulrich A. K. Betz, Gustavo Arruda Bezerra, Paul E. Brennan, David Brown, Peter J. Brown, Alex N. Bullock, Adrian J. Carter, Apirat Chaikuad, Mathilde Chaineau, Alessio Ciulli, Ian Collins, Jan Dreher, Kristina Edfeldt, Aled M. Edwards, Ursula Egner, Stephen M. Fuchs, Matthew D. Hall, Ingo V. Hartung, Alexander Hillisch, Stephen H. Hitchcock, Evert Homan, Natarajan Kannan, James R. Kiefer, Stefan Knapp, Milka Kostic, Stefan Kubicek, Andrew R. Leach, Sven Lindemann, Hisanori Matsui, Jordan L. Meier, Maurice Michel, Maxwell R. Morgan, Anke Mueller-Fahrnow, Dafydd R. Owen, Benjamin G. Perry, Saul H. Rosenberg, Kumar Singh Saikatendu, Cora Scholten, Sujata Sharma, Anton Simeonov, Michael Sundström, Matthew H. Todd, Claudia Tredup, Timothy M. Willson, Georg E. Winter

2021-12-03 Opinion

DOI: 10.1039/D1MD00228G

Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents‡

Bandi Siva, Sravanthi Vadlamudi, Surendar Reddy Bathula, Hashnu Dutta, K. Suresh Babu

2021-04-26 Research Article

DOI: 10.1039/D0MD00315H

Macrocyclization strategies for cyclic peptides and peptidomimetics

Clément Bechtler, Christina Lamers

2021-06-29 Review Article

DOI: 10.1039/D1MD00083G

Macrocyclic peptides that inhibit Wnt signalling via interaction with Wnt3a

Manuel E. Otero-Ramirez, Kyoko Matoba, Emiko Mihara, Junichi Takagi, Hiroaki Suga

2020-03-24 Paper

DOI: 10.1039/D0CB00016G

Structural modifications that increase gut restriction of bile acid derivatives

Ali Nakhi, Henry L. Wong, Peter I. Dosa

2021-02-12 Research Article

DOI: 10.1039/D0MD00425A

Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and study of their interaction with G-quadruplex DNA

Ushasri Chilakamarthi, Namita S. Mahadik, Bhamidipati Keerti, Santosh N. Mokale, Narayana Nagesh

2021-02-22 Research Article

DOI: 10.1039/D0MD00414F

Profiling MAP kinase cysteines for targeted covalent inhibitor design

Ruibin Liu, Neha Verma, Jack A. Henderson, Shaoqi Zhan, Jana Shen

2021-11-03 Research Article

DOI: 10.1039/D1MD00277E

Front cover

Cover

DOI: 10.1039/D0MD90043E

You might also like

Compound Q&A

What are the main uses of (3alpha,5alpha)-3-Hydroxypregnane-11,20-dione (CAS: 23930-19-0)?

(3alpha,5alpha)-3-Hydroxypregnane-11,20-dione is primarily used in the pharmaceu...

23930-19-0(3alpha,5alpha)-3-Hy...
Compound Q&A

What is the market or research trend for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4)?

The market for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4) is ...

546141-56-44-Amino-6-chloro-2-p...
Compound Q&A

Are there alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in synthesis?

Alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in ...

24472-88-6(2-Benzoylethyl)trim...
Compound Q&A

Is N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) safe?

N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) is generally safe...

393-12-4N-[4-Nitro-3-(triflu...
Compound Q&A

Are there alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-14-5) in synthesis?

There are alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-...

4605-14-5N,N'-Bis(3-aminoprop...
Compound Q&A

What precautions should be taken when handling Aluminium trihexadecanoate (CAS: 555-35-1)?

When handling Aluminium trihexadecanoate, it is important to use appropriate per...

555-35-1Aluminium trihexadec...
Compound Q&A

What is (1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid (CAS: 52188-11-1)?

(1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid is a chemical compound ...

52188-11-1(1,1-Dioxido-3-oxo-1...
Compound Q&A

Are there alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) in synthesis?

Several alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) can be used in...

3123-97-55,5-dimethyloxolan-2...

Source Journal

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
Self-citation Rate: 10.3%
Articles per Year: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.